Replication of functional serotonin receptor type 3A and B variants in bipolar affective disorder: A European multicenter study

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Hammer, C ^a   Cichon, S ^b,c   Muhleisen T W ^b   Haenisch, B ^b   Degenhardt, F ^b   Mattheisen, M ^b,d,e   Breuer, R ^f   Witt, S H ^f   Strohmaier, J ^f   Oruc, L ^g   Rivas, F ^h   Babadjanova, G ⁱ   Grigoroiu Serbanescu, M ^j   Hauser, J ^k   Roth R ^a   Rappold, G ^a   Rietschel, M ^f   Nothen M M ^b,l   Niesler, B ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF MANNHEIM   (Germany)

^g UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^h HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

ⁱ PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^j Psychiatric Hospital Bucharest   (Romania)

^k Laboratory of Psychiatric Genetics   (Poland)

^l GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

more..

Author keywords

5 HT3; association; bipolar; BPAD; HTR3; HTR3B

Indexed keywords

MESSENGER RNA; SEROTONIN 3 RECEPTOR; SEROTONIN RECEPTOR TYPE 3A; SEROTONIN RECEPTOR TYPE 3B; UNCLASSIFIED DRUG; HTR3A PROTEIN, HUMAN; HTR3B PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BRAIN STEM; BRAIN TISSUE; CEREBELLUM; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FETUS; FRONTAL CORTEX; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; MENTAL DISEASE; MULTICENTER STUDY; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ANXIETY DISORDER; BRAIN; CASE CONTROL STUDY; COMORBIDITY; EUROPE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GENOTYPE; METABOLISM; PHENOTYPE; PRENATAL DEVELOPMENT; SEX DIFFERENCE;

ADULT; ALLELES; ANXIETY DISORDERS; BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; COMORBIDITY; EUROPE; FEMALE; FETUS; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SEROTONIN, 5-HT3; RNA, MESSENGER; SEX FACTORS;

EID: 84859799419     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.30     Document Type: Article

References (45)

1. Rajkumar R, Mahesh R. The auspicious role of the 5-HT3 receptor in depression: A probable neuronal target? J Psychopharmacol 2010; 24: 455-469.
2. Niesler B. 5-HT(3) receptors: Potential of individual isoforms for personalised therapy. Curr Opin Pharmacol 2011; 11: 81-86.
3. Walstab J, Rappold G, Niesler B. 5-HT(3) receptors: Role in disease and target of drugs. Pharmacol Ther 2010; 128: 146-169.
4. Niesler B, Frank B, Kapeller J, Rappold GA. Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 2003; 310: 101-111. (Pubitemid 36703304)
5. Abi-Dargham A, Laruelle M, Wong DT, Robertson DW, Weinberger DR, Kleinman JE. Pharmacological and regional characterization of [3H]LY278584 binding sites in human brain. J Neurochem 1993; 60: 730-737. (Pubitemid 23030974)
6. Barnes JM, Barnes NM, Costall B, Ironside JW, Naylor RJ. Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue. J Neurochem 1989; 53: 1787-1793. (Pubitemid 19283648)
7. Bufton KE, Steward LJ, Barber PC, Barnes NM. Distribution and characterization of the [3H]granisetron-labelled 5-HT3 receptor in the human forebrain. Neuropharmacology 1993; 32: 1325-1331.
8. Parker RM, Barnes JM, Ge J, Barber PC, Barnes NM. Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain. J Neurol Sci 1996; 144: 119-127. (Pubitemid 27019167)
9. Belelli D, Balcarek JM, Hope AG, Peters JA, Lambert JJ, Blackburn TP. Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit. Mol Pharmacol 1995; 48: 1054-1062.
10. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S. Molecular cloning of human 5- hydroxytryptamine3 receptor: Heterogeneity in distribution and function among species. Mol Pharmacol 1995; 48: 407-416.
11. Jensen AA, Davies PA, Brauner-Osborne H, Krzywkowski K. 3B but which 3B and that's just one of the questions: The heterogeneity of human 5-HT3 receptors. Trends Pharmacol Sci 2008; 29: 437-444.
12. Frank B, Niesler B, Nothen MM, Neidt H, Propping P, Bondy B et al. Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2004; 131B: 1-5. (Pubitemid 39458429)
13. Niesler B, Weiss B, Fischer C, Nothen MM, Propping P, Bondy B et al. Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics 2001; 11: 21-27. (Pubitemid 32108658)
14. Kapeller J, Houghton LA, Monnikes H, Walstab J, Moller D, Bonisch H et al. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 2008; 17: 2967-2977.
15. Ji X, Takahashi N, Branko A, Ishihara R, Nagai T, Mouri A et al. An association between serotonin receptor 3B gene (HTR3B) and treatment-resistant schizophrenia (TRS) in a Japanese population. Nagoya J Med Sci 2008; 70: 11-17.
16. Krzywkowski K, Davies PA, Feinberg-Zadek PL, Brauner-Osborne H, Jensen AA. Highfrequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor. Proc Natl Acad Sci USA 2008; 105: 722-727. (Pubitemid 351171775)
17. Krzywkowski K, Davies PA, Irving AJ, Brauner-Osborne H, Jensen AA. Characterization of the effects of four HTR3B polymorphisms on human 5-HT3AB receptor expression and signalling. Pharmacogenet Genomics 2008; 18: 1027-1040.
18. Meineke C, Tzvetkov MV, Bokelmann K, Oetjen E, Hirsch-Ernst K, Kaiser R et al. Functional characterization of a -100-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene. Pharmacogenet Genomics 2008; 18: 219-230. (Pubitemid 351323237)
19. Walstab J, Hammer C, Bonisch H, Rappold G, Niesler B. Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors. Pharmacogenet Genomics 2008; 18: 793-802.
20. Hammer C, Kapeller J, Endele M, Fischer C, Hebebrand J, Hinney A et al. Functional variants of the serotonin receptor type 3A and B gene are associated with eating disorders. Pharmacogenet Genomics 2009; 19: 790-799.
21. Yamada K, Hattori E, Iwayama Y, Ohnishi T, Ohba H, Toyota T et al. Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol Psychiatry 2006; 60: 192-201.
22. Iidaka T, Ozaki N, Matsumoto A, Nogawa J, Kinoshita Y, Suzuki T et al. A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J Neurosci 2005; 25: 6460-6466. (Pubitemid 40965551)
23. Kilpatrick LA, Labus JS, Coveleskie K, Hammer C, Rappold G, Tillisch K et al. The HTR3A polymorphism c. -42C4T is associated with amygdala responsiveness in patients with irritable bowel syndrome. Gastroenterology 2011; 140: 1943-1951.
24. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006; 32: 9-16. (Pubitemid 43063811)
25. Cichon S, Muhleisen TW, Degenhardt FA, Mattheisen M, Miro X, Strohmaier J et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 2011; 88: 372-381.
26. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-678.
27. Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W et al. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 2009; 14: 755-763.
28. Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, Bagoutdinov R et al. The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 2007; 39: 1181-1186. (Pubitemid 47482671)
29. Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, Estivill X et al. SNPassoc: An R package to perform whole genome association studies. Bioinformatics 2007; 23: 644-645. (Pubitemid 46522604)
30. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150. (Pubitemid 36150192)
31. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
32. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 2008; 26: 317-325. (Pubitemid 351355126)
33. Costall B, Naylor RJ, Tyers MB. The psychopharmacology of 5-HT3 receptors. Pharmacol Ther 1990; 47: 181-202.
34. Kelley SP, Bratt AM, Hodge CW. Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice. Eur J Pharmacol 2003; 461: 19-25. (Pubitemid 36144260)
35. Bhatnagar S, Nowak N, Babich L, Bok L. Deletion of the 5-HT3 receptor differentially affects behavior of males and females in the Porsolt forced swim and defensive withdrawal tests. Behav Brain Res 2004; 153: 527-535. (Pubitemid 38953130)
36. Bhatnagar S, Vining C. Pituitary-adrenal activity in acute and chronically stressed male and female mice lacking the 5-HT-3A receptor. Stress 2004; 7: 251-256. (Pubitemid 40591425)
37. Lecrubier Y, Puech AJ, Azcona A, Bailey PE, Lataste X. A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology (Berl) 1993; 112: 129-133. (Pubitemid 23261866)
38. Hewlett WA, Schmid SP, Salomon RM. Pilot trial of ondansetron in the treatment of 8 patients with obsessive-compulsive disorder. J Clin Psychiatry 2003; 64: 1025-1030. (Pubitemid 37158247)
39. Chameau P, Inta D, Vitalis T, Monyer H, Wadman WJ, van Hooft JA. The N-terminal region of reelin regulates postnatal dendritic maturation of cortical pyramidal neurons. Proc Natl Acad Sci USA 2009; 106: 7227-7232.
40. Buxhoeveden DP, Casanova MF. The minicolumn hypothesis in neuroscience. Brain 2002; 125(Part 5): 935-951. (Pubitemid 34464606)
41. Walstab J, Hammer C, Lasitschka F, Moller D, Connolly CN, Rappold G et al. RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits. J Biol Chem 2010; 285: 26956-26965.
42. Miquel MC, Emerit MB, Nosjean A, Simon A, Rumajogee P, Brisorgueil MJ et al. Differential subcellular localization of the 5-HT3-As receptor subunit in the rat central nervous system. Eur J Neurosci 2002; 15: 449-457. (Pubitemid 35463663)
43. Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res 2008; 195: 198-213.
44. Barnes NM, Hales TG, Lummis SC, Peters JA. The 5-HT3 receptor-the relationship between structure and function. Neuropharmacology 2009; 56: 273-284.
45. Niesler B, Flohr T, Nothen MM, Fischer C, Rietschel M, Franzek E et al. Association between the 50 UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 2001; 11: 471-475. (Pubitemid 32778225)